Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BALSALAZIDE DISODIUM DIHYDRATE USP, with a corresponding US DMF Number 17326.
Remarkably, this DMF maintains an Active status since its submission on April 19, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 07, 2013, and payment made on July 30, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II